Logo
Menu
  • Who We Are
  • How We Invest
  • Our Portfolio
    • Abzena
    • Ixlayer
    • Kiniciti
    • PathAI
  • Blog
  • Careers
  • Contact
Vaccines, Return to Work & the Economy

Vaccines, Return to Work & the Economy

by Biospring | Apr 26, 2022 | Astrazeneca, Biospring Partners, COVID-19, Economy, Jay Bradner, Katie Burke, Novartis, Oxford, Peter B. Henry, Return to work, Sir John Bell, Vaccines

Last December, we hosted a discussion with industry leaders on COVID-19 and Vaccines, Return-to-Work, and the Economy. We were delighted to host Dr. Jay Bradner, President of the Novartis Institutes for BioMedical Research (NIBR) and Biospring’s advisors Sir...
Professor Graham Richards on Computer-Aided Molecular Design

Professor Graham Richards on Computer-Aided Molecular Design

by Biospring | Apr 24, 2022 | Chemistry, Computer Aided Molecular Design, Drug Design, Graham Richards, Oxford, Pharma

Professor Graham Richards is Commander of the Order of the British Empire and former Head of Chemistry at the University of Oxford. He is a pioneer in the field of computational chemistry and computer-aided molecular design, particularly as it applies to the...

Recent Posts

  • Biospring Partners Welcomes Industry Executives To Its Advisory Board
  • Biomanufacturing: A Growing Field
  • Interview with Zach Weinberg
  • Driving Drug Development with Data Science
  • Proteomics 101

Recent Comments

No comments to show.

Newsletter

Thank you for subscribing!

Subscribe